evenfolioETF Details
Virtus·Health·BBP · NYSE Arca
Virtus Biotech ETF (BBP)
- Price
- $104.18
- —30 Oct 2026
- Assets
- $131.5M
- Total net assets
- Expense ratio
- 0.34%
- Category 1.00%
- Yield
- 0.00%
- Trailing distributions
- 1Y return
- 42.6%+13.7%
- Category 28.8%
- 3Y CAGR
- 31.2%+9.7%
- Category 21.5%
- 5Y CAGR
- 15.0%+10.9%
- Category 4.1%
Loading NAV history…
Virtus Biotech ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -1.3% | +11.0% | +22.6% | +30.4% | +42.6% | +31.2% | +15.0% | +13.6% | +12.5% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -4.9% | +1.1% | -0.4% | +9.9% | +13.7% | +9.7% | +10.9% | +2.8% | +0.9% |
Holdings
The 10 largest positions make up 26.9% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| MRNA | Moderna Inc | 4.94% |
| IOVA | Iovance Biotherapeutics Inc | 4.65% |
| OMER | Omeros Corp | 2.79% |
| VSTM | Verastem Inc | 2.52% |
| PGEN | Precigen Inc | 2.46% |
| HALO | Halozyme Therapeutics Inc | 2.04% |
| ZLAB | Zai Lab Ltd ADR Repr 1 Shs | 1.98% |
| RIGL | Rigel Pharmaceuticals Inc | 1.88% |
| KNSA | Kiniksa Pharmaceuticals International PLC Class A | 1.84% |
| XERS | Xeris Biopharma Holdings Inc | 1.80% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 5.3
- P/S
- 6.3
- P/CF
- —
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.7%
- Cash0.3%
ETF details
- Issuer
- Virtus
- Category
- Equity · Health
- Ticker
- BBP
- Exchange
- NYSE Arca
- Inception
- 16 Dec 2014 (11.9 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.34% (category 1.00%)
- Holdings turnover
- 46% (category 51%)
- Distribution yield
- 0.00%
- Beta, 3 years
- 0.73
- Total net assets
- $131.5M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- LFSC · F/M Emerald Life Sciences Innovation ETFEmerald Mutual Fund Advisers Trust · $123.4M · ER 0.54%
- IBBQ · Invesco Nasdaq Biotechnology ETFInvesco · $103.3M · ER 0.19%5Y 8.7%
- GNOM · Global X Genomics & Biotechnology ETFGlobal X Funds · $102.9M · ER 0.50%5Y -3.8%
- AGNG · Global X Aging Population ETFGlobal X Funds · $88.9M · ER 0.50%5Y 6.8%
- HTEC · ROBO Global Healthcare Technology and Innovation ETFRobo Global · $76.3M · ER 0.68%5Y -0.3%
- OZEM · Roundhill GLP-1 & Weight Loss ETFRoundhill Investments · $57.8M · ER 0.59%